Home
/
HARVARD BIOSCIENCE INC
/
Financials
/
Quarterly
HARVARD BIOSCIENCE INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that HARVARD BIOSCIENCE INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2020
Mar 31, 2020
$23.77M
May 8, 2020
Q3
2019
Sep 30, 2019
$27.42M
Nov 8, 2019
Q2
2019
Jun 30, 2019
$29.58M
Aug 8, 2019
Q1
2020
Mar 31, 2019
$28.20M
May 8, 2020
Q3
2019
Sep 30, 2018
$28.64M
Nov 8, 2019
Q2
2019
Jun 30, 2018
$31.52M
Aug 8, 2019
Q1
2019
Mar 31, 2018
$26.76M
May 8, 2019
Q3
2018
Sep 30, 2017
$18.72M
Nov 1, 2018
Q2
2018
Jun 30, 2017
$18.96M
Aug 2, 2018
Q1
2018
Mar 31, 2017
$18.09M
May 10, 2018
Q3
2017
Sep 30, 2016
$25.01M
Nov 2, 2017
Q2
2017
Jun 30, 2016
$26.14M
Aug 3, 2017
Q1
2017
Mar 31, 2016
$26.96M
May 8, 2017
Q3
2016
Sep 30, 2015
$25.73M
Nov 3, 2016
Q2
2016
Jun 30, 2015
$28.80M
Aug 4, 2016
Q1
2016
Mar 31, 2015
$25.76M
May 16, 2016
Q3
2015
Sep 30, 2014
$25.45M
Nov 5, 2015
Q2
2015
Jun 30, 2014
$26.96M
Aug 6, 2015
Q1
2015
Mar 31, 2014
$25.89M
May 7, 2015
Q3
2014
Sep 30, 2013
$25.14M
Nov 6, 2014
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$20.59M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$20.45M
Aug 11, 2025
Q1
2025
Mar 31, 2025
$21.77M
May 12, 2025
Q3
2025
Sep 30, 2024
$21.97M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$23.10M
Aug 11, 2025
Q1
2025
Mar 31, 2024
$24.51M
May 12, 2025
Q3
2024
Sep 30, 2023
$25.36M
Nov 8, 2024
Q2
2024
Jun 30, 2023
$28.76M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$29.98M
May 7, 2024
Q3
2023
Sep 30, 2022
$26.92M
Nov 7, 2023
Q2
2023
Jun 30, 2022
$29.21M
Aug 8, 2023
Q1
2023
Mar 31, 2022
$28.78M
Apr 26, 2023
Q3
2022
Sep 30, 2021
$29.66M
Nov 9, 2022
Q2
2022
Jun 30, 2021
$29.20M
Aug 4, 2022
Q1
2022
Mar 31, 2021
$26.99M
May 4, 2022
Q3
2021
Sep 30, 2020
$24.04M
Nov 5, 2021
Q2
2021
Jun 30, 2020
$23.31M
Aug 6, 2021
Q1
2021
Mar 31, 2020
$23.77M
May 7, 2021
Q3
2020
Sep 30, 2019
$27.42M
Nov 6, 2020
Q2
2020
Jun 30, 2019
$29.58M
Aug 10, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($1.23M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($2.28M)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($50.34M)
May 12, 2025
Q3
2025
Sep 30, 2024
($4.80M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($2.93M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($4.69M)
May 12, 2025
Q3
2024
Sep 30, 2023
($1.24M)
Nov 8, 2024
Q2
2024
Jun 30, 2023
($980.0K)
Aug 8, 2024
Q1
2024
Mar 31, 2023
$622.0K
May 7, 2024
Q3
2023
Sep 30, 2022
($3.41M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
$2.44M
Aug 8, 2023
Q1
2023
Mar 31, 2022
($6.88M)
Apr 26, 2023
Q3
2022
Sep 30, 2021
($170.0K)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($410.0K)
Aug 4, 2022
Q1
2022
Mar 31, 2021
($669.0K)
May 4, 2022
Q3
2021
Sep 30, 2020
($1.10M)
Nov 5, 2021
Q2
2021
Jun 30, 2020
($1.58M)
Aug 6, 2021
Q1
2021
Mar 31, 2020
($4.52M)
May 7, 2021
Q3
2020
Sep 30, 2019
($2.62M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
($247.0K)
Aug 10, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$197.0K
Nov 6, 2025
Q2
2025
Jun 30, 2025
($819.0K)
Aug 11, 2025
Q1
2025
Mar 31, 2025
($49.67M)
May 12, 2025
Q3
2025
Sep 30, 2024
($1.87M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($2.07M)
Aug 11, 2025
Q1
2025
Mar 31, 2024
($2.28M)
May 12, 2025
Q3
2024
Sep 30, 2023
($933.0K)
Nov 8, 2024
Q2
2024
Jun 30, 2023
$796.0K
Aug 8, 2024
Q1
2024
Mar 31, 2023
$1.75M
May 7, 2024
Q3
2023
Sep 30, 2022
($3.76M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
$4.00M
Aug 8, 2023
Q1
2023
Mar 31, 2022
($6.71M)
Apr 26, 2023
Q3
2022
Sep 30, 2021
$548.0K
Nov 9, 2022
Q2
2022
Jun 30, 2021
$58.0K
Aug 4, 2022
Q1
2022
Mar 31, 2021
($239.0K)
May 4, 2022
Q3
2021
Sep 30, 2020
$182.0K
Nov 5, 2021
Q2
2021
Jun 30, 2020
$556.0K
Aug 6, 2021
Q1
2021
Mar 31, 2020
($3.27M)
May 7, 2021
Q3
2020
Sep 30, 2019
($1.37M)
Nov 6, 2020
Q2
2020
Jun 30, 2019
$228.0K
Aug 10, 2020